menu search

LUNG / Pulmonx: An Ideal Takeout Candidate

Pulmonx: An Ideal Takeout Candidate
Pulmonx has an FDA-approved technology to treat severe emphysema. The company estimates its valve treatment is a $12 billion market opportunity. Read More
Posted: Nov 10 2022, 02:29
Author Name: Seeking Alpha
Views: 103112

LUNG News  

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 6, 2023

Pulmonx Corporation (LUNG) Q2 2023 Earnings Call Transcript

Pulmonx Corporation (NASDAQ:LUNG ) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Dorothy Morgan - Investor Relations more_horizontal

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

By GlobeNewsWire
July 26, 2023

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

REDWOOD CITY, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive trea more_horizontal

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

By GlobeNewsWire
July 15, 2023

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

REDWOOD CITY, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive trea more_horizontal

Pulmonx Corporation (LUNG) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 2, 2023

Pulmonx Corporation (LUNG) Q1 2023 Earnings Call Transcript

Pulmonx Corporation (NASDAQ:LUNG ) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Laine Morgan - Investor Relations Glen more_horizontal

Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates

By Zacks Investment Research
May 2, 2023

Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates

Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to more_horizontal

7 Nasdaq Small-Cap Stocks Set to Outperform in 2023

By InvestorPlace
April 27, 2023

7 Nasdaq Small-Cap Stocks Set to Outperform in 2023

Though common sense tells us to load up on securities with established track records, the concept of Nasdaq small-cap stocks to buy invariably deliver more_horizontal

Pulmonx Corporation (LUNG) Q4 2022 Earnings Call Transcript

By Seeking Alpha
February 22, 2023

Pulmonx Corporation (LUNG) Q4 2022 Earnings Call Transcript

Pulmonx Corporation. (NASDAQ:LUNG ) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ET Company Participants Laine Morgan - Investor Relatio more_horizontal

Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates

By Zacks Investment Research
February 22, 2023

Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 7.32% and 11.27%, respectively, for the quarter ended December 2022. Do the num more_horizontal


Search within

Pages Search Results: